Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Scalp nerve block with liposomal bupivacaine for post-craniotomy analgesia
ChiCTR2600124916Phase 4Not yet recruiting
- Sponsor
- Renji Hospital
- Start
- May 2026
- Modality
- Small Molecules, Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of liposomal bupivacaine in postoperative pain (2 arms), sponsored by Renji Hospital. Primary endpoint: Quality of Recovery-15 score at 48 hours post-surgery. Planned start May 2026; status: not yet recruiting.
02
Drugs
liposomal bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2600124916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2600124916.